Notes to SEFA
The accompanying schedule of expenditures of federal awards includes the federal grant activity of Dayton Clinical Oncology Program (DCOP) under programs of the federal government for the year ended May 31, 2025. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. Therefore, some amounts presented in this schedule may differ from amounts presented in, or used in the preparation of the basic financial statements. Because the schedule presents only a selected portion of the operations of DCOP it is not intended to and does not present the financial position, changes in net assets, or cash flows of DCOP.